These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10488246)

  • 41. Carbonic anhydrase inhibitors: synthesis and inhibition against isozymes I, II and IV of topically acting antiglaucoma sulfonamides incorporating cis-5-norbornene-endo-3-carboxy-2-carboxamido moieties.
    Casini A; Mincione F; Ilies MA; Menabuoni L; Scozzafava A; Supuran CT
    J Enzyme Inhib; 2001; 16(2):113-23. PubMed ID: 11342280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV by sulfamide and sulfamic acid derivatives.
    Scozzafava A; Banciu MD; Popescu A; Supuran CT
    J Enzyme Inhib; 2000; 15(5):443-53. PubMed ID: 11030084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sulfenamido-sulfonamides as inhibitors of carbonic anhydrase isozymes I, II and IV.
    Supuran CT; Briganti F; Scozzafava A
    J Enzyme Inhib; 1997 Aug; 12(3):175-90. PubMed ID: 9314114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyes.
    Carta F; Pothen B; Maresca A; Tiwari M; Singh V; Supuran CT
    Chem Biol Drug Des; 2009 Aug; 74(2):196-202. PubMed ID: 19549076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
    Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides.
    Abdoli M; Angeli A; Bozdag M; Carta F; Kakanejadifard A; Saeidian H; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1071-1078. PubMed ID: 28753093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity.
    Ilies MA; Masereel B; Rolin S; Scozzafava A; Câmpeanu G; Cîmpeanu V; Supuran CT
    Bioorg Med Chem; 2004 May; 12(10):2717-26. PubMed ID: 15110853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.
    Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT
    Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
    Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.
    Brzozowski Z; Sławiński J; Saczewski F; Innocenti A; Supuran CT
    Eur J Med Chem; 2010 Jun; 45(6):2396-404. PubMed ID: 20202722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII.
    Güzel-Akdemir Ö; Akdemir A; Isik S; Vullo D; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1386-91. PubMed ID: 23352754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carbonic anhydrase inhibitors. Inhibition of red blood cell ostrich (Struthio camelus) carbonic anhydrase with a series of aromatic and heterocyclic sulfonamides.
    Ozensoy O; Isik S; Arslan O; Arslan M; Scozzafava A; Supuran CT
    J Enzyme Inhib Med Chem; 2005 Aug; 20(4):383-7. PubMed ID: 16206834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carbonic anhydrase inhibitors: Synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety.
    Sethi KK; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5168-74. PubMed ID: 23867389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.
    Pastorekova S; Casini A; Scozzafava A; Vullo D; Pastorek J; Supuran CT
    Bioorg Med Chem Lett; 2004 Feb; 14(4):869-73. PubMed ID: 15012984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.
    Scozzafava A; Supuran CT
    J Med Chem; 2000 Oct; 43(20):3677-87. PubMed ID: 11020282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII.
    Güzel O; Maresca A; Scozzafava A; Salman A; Balaban AT; Supuran CT
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2931-4. PubMed ID: 19410461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
    de Leval X; Ilies M; Casini A; Dogné JM; Scozzafava A; Masini E; Mincione F; Starnotti M; Supuran CT
    J Med Chem; 2004 May; 47(11):2796-804. PubMed ID: 15139757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides.
    Akdemir A; Güzel-Akdemir O; Scozzafava A; Capasso C; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5228-32. PubMed ID: 23842519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides.
    Pastorekova S; Vullo D; Casini A; Scozzafava A; Pastorek J; Nishimori I; Supuran CT
    J Enzyme Inhib Med Chem; 2005 Jun; 20(3):211-7. PubMed ID: 16119190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.